<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 322 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page321.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=322">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 322 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 322</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=322"><img src="../thumb/322.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Anti-Microbials  - 18.12                                                       2020-04 / 285
       ano-genit. mucous membr., CMV infect. prophylax., CMV dis.& other   Special precautions: Ren.funct.impairm., liv. dis., maint.adeq.  Interactions: Plasma conc.poss.altered by CYP3A substr. inhibits./
       herpes vir.infect. prophylax. aft.organ transplant in spec.risk cases.  hydrat., no data on effectiven.in genital herpes if init.&gt;24 hrs.aft.   induc., plasma conc.of other compds. that are CYP3A4 substrat.
       (S4) TABS. 44/20.2.8/0016     onset of S&S, teratogenicity in animals, concom.meds.which aff.  poss.decr., incr. CNS eff.with alcoh./psychoact.meds., AUC & C max
       720931-001: 500 mg, 10, R195,05  ren.physiolog./compete with acyclovir for eliminat., incr.in plasma   of indinavir decr., incr.freq.of S/E with ritonavir, decr. saquinavir/
       720931-002: 500 mg, 30, R585,16  AUC’s of acyclovir & inact.metabolite of mycophenolate mofetil.  clarithromycin. AUC & C max , reduc. AUC & C max with rifampicin, po-
       720931-003: 500 mg, 42, R819,22                            tent.interact with OC’s, methadone plasma lev.decr.result.in opiate
       Dosage: Adults: Herpes zoster: 1 000 mg 3x/dly for 7 days.  ZELIVIRE 500, Ranbaxy [P/S]  withdr. signs in HIV infect.IV drug users, decr.eff.of carbamazepine &
       Recurr.genit.herpes: Immunocompet.pts: 500 mg 2x/day   Valaciclovir.  efavirenz, potent.for reduc.eff.of phenytoin/phenobarb.&/efavirenz
       x5 days start.as early as poss. Init. within 24 hrs.of S&S onset./  Indications: Herpes zoster (shingles), recurr. genit. herpes.in im-  plasma lev., decr. atorvastatin/pravastatin/simvastatin plasma lev.,
       dur.prodromal.per.            munocompetent pts., prevent/ suppress.of recurr.H.simplex infect.  reduc.conc.with St John’s Wort.
       Prevent./suppress.of recurr.H.Simplex: Immunocompet.pts:   of skin & ano-genit.mucous membr., CMV infect.prophylax., CMV
       500 mg once dly. Admin. 250 mg 2x dly.if more than 10 episod.oc-  dis. & other herpes infects.follow.organ transplant.  ZENVIR, (Activo) Aurobindo [P/S]
       cur/yr. Immunocomprom.pts: 500 mg 2xdly.  (S4) TABS. 42/20.2.8/0476  Efavirenz.
       CMV infect.prophylax: Adults & adolesc. 12 yrs. & old: Init.  715249-001: 500 mg, 30, R686,58  Indications: In combinat.with other antiretrovir. agents for HIV-1
       ther.as soon as poss. Post-transpl: 2 000 mg 4xdly usual.x90 days.   Dosage: Childr: No data avail.  infect.adults, adolesc.& childr. 13 kg & above and/ or 3 yrs and above.
       Poss. extend. treatm.durat.in high-risk pts. Reduc.dos. accord. to   Adults:  (S4) CAPS, 41/20.2.8/0538,0540
       creatin.clear.                Herpes zoster: 1 000 mg 3x/day x7 days.  720840-001: 50 mg, 30, R47,79
       Contraindications: Acyclovir hypersens., safety in pregn.& lactat.  Recurr.genit.herpes: No data on effectiven.if init more than 24   720841-001: 200 mg, 90, R256,16
       not est., no data avail.for childr.  hrs.aft S&S onset. 500 mg 2x/day x5 days.  Dosage: Admin.in combinat.with a protease inhibit. and/or nu-
       Side effects: Hypersens.reacts.incl.anaphylax./ angioed., CNS   Prevent./suppress.of recurr.H.Simplex infect: Immunocom-  cleoside analog.revers.transcript. inhibit. Admin.on empty stom-
                                                                                      st
       effs., headache, dizzin., confus., GI disturbs., skin reacts.incl.  petent pts: 500 mg dly. Freq.recurr. of more than 10 episodes/yr:   ach.pref.at bedt. Bedt. dos.recomm.esp.dur.1  2-4 wks ther.& in
       erythema multiforme/ tox.epiderm. necrolys./Stev.Johns.syndr.,   250 mg 2xdly. Immunocomprom.pts: 500 mg 2xdly.  pts.exper. CNS effs.
       ac.ren. fail.                 CMV infect.& dis. prophylax: Adults & adolesc. 12 yrs& over:   Adults: Recomm.dos: 600 mg once dly. Adolesc. & childr.17 yrs.&
       Warnings and special precautions: Thrombot. thrombocyto-  2 000 mg 4xdly x90 days. poss.extent.in high risk pts. Init.ther.as early   und. weigh.≥ 40 kg: 600 mg at bedt. Use only in adults & childr.
       pen. purpura/haemolyt.uraem.syndr. poss. result.in death in pts.  as poss. post-transpl. Modify dos.accord.to creatin. clear.  weigh.≥ 40 kg.
       with advanc. HIV dis./ aft.bone marr.& ren.transpl., elderly, ren.  Contraindications: Valaciclov./acyclovir hypersens., safety in   Concom.antiretrovir.ther: Zenvir must be giv.in combin. with
       funct. impairm., liv.dis., underly.ren.dis., potent. nephrotox. meds.,   pregn.& lactat.not est.  other antiretrovir.meds.
       maint.adeq.hydrat., discont.ther. if CNS adverse reacts.occur, con-  Side effects: Bld dyscras., hypersens.reacts. incl. anaphylax., head-  Contraindications: Concom.terfenadine/ astemizole/ cisapride/
       com.meds. compet. with acyclovir for elimin.potent.incr. plasma lev.  ache, CNS effs.incl.psychos. /encephalopathy & coma esp.in ren.  midazolam/triazolam/ergot derivat. as ser./ life threat.adverse
       of one/both meds., no data on effic.if init. more than 24 hrs.aft.S&S   impairm.where recomm. dos.exceed., GI disords., naus., abdom.   effs.poss., pregn., lactat., childr.und.3 yrs./weight &lt; 13 kg, con-
       onset in recurr. genit. herpes., other concom.meds.aff.ren.physiol.   pain, hepatit., jaund., ac.ren.fail., diffuse hair.loss.  com.St John’s Wort.
       incl.cyclospor./tacrolimus    Special precautions: Concom.meds.affect.ren. physiolog./ com-  Side effects: Weight chang., CNS effs., dizzin., headache, convuls.,
       Interactions: Probenec.decr.ren.excret., plasma AUC’s of aciclovir &   pet.with aciclovir for elimin., incr.in plasma AUC’s of aciclovir & in-  hypoesthes., paraesthes., periph. neuropathy, trem., psych.effs., oste-
       mycophenolate mofetil both incr. when admin.concom.  act.metabolite of mycophenolate mofetil., ren.funct.impairm., maint.   onecros., speech disord., vertigo, neuralg., abnorm. vis., tinnit., flush.,
                                                                  palpitat., tachycard., asthma, URTI, sinusit., dyspn., GI disords.incl.
                                     adeq. hydrat., no data avail.on high dos.in liv.dis./ liv. transplantat.,
       ZEFIN, Novagen [P/S]          admin.aft.haemodialys., liv.dis., teratogenicity in rats.  gastro-oesophag.refl., taste pervers., incr.appet., malabsorpt., hepatit.,
       Tenofovir disoproxil fumarate  Warnings: Thrombot., thrombocytopen.uraem. syndr. poss.result.  hepat.fail., hepat.enzyme incr., skin reacts.incl.erythema multiforme/
       Indications: In combinat.with other antiretrovir. for HIV-1 in-  in death in pts.with advanc.HIV dis./bone marr.& ren.transpl.pts.  Stev. John.syndr., incr.sweat., alopec., nail disords., skin discolourat.,
       fect.treatm.                                               arthralg./myalg., myopathy, impot., libido chang., fatig., alcoh.intol., al-
       (S4) TABS, 44/20.2.8/0307     ZENFAR 600, (Activo) Macleods [P/S]  lerg.reacts., asthen., hot flush., flu-like sympts., malaise, pain, syncope,
       715072-001: 300 mg, 30, R300,46  Efavirenz                 body fat redistribut./accumulat., rais.ser. cholester./triglycerid.conc.
       Dosage: 300 mg once dly.      Indications: In combinat.with other antiretrovir. agents for HIV-1   Warnings and special precautions: Teratogenicity in animals,
       Contraindications: Mod.to sev.ren.fail., safety in pregn.& lactat.  infect.adults, adolesc.& childr. weigh.40 kg and above.  use barrier contracept.in combinat. with other methods, pregn.test
       not est., safety & effic.in pts. &lt;18 yrs./ hepatit.B vir.co-infects.not est.  (S4) TABS, 45/20.2.8/0084  in women of childbear.potent.bef.init.ther., poss. pass. into breast
       Side effects: Lactic.acidos.& sev.hepatomegaly with steatos.incl.  3000055-001: 600 mg, 30, R200,00  milk, must not be used as monother./ add.on as sole agent to fail.
       fatal.esp.women, ren.impairm., ac.ren.fail., fanconi syndr., GI dis-  Dosage: Admin.in combinat.with a protease inhibit. &/ NRTI. Ad-  regim., clinic. exam.to incl.evaluat.for phys.signs of lipodystrophy, if
                                                             st
       turbs., pancreatit., depress., headache, insomn., periph. neuropa-  min.on empty stomach pref.at bedt. Consid.bedt.dos.dur.1  2-4 wks   lipodystrophy evid.pres.do a CV risk assessm., immune reconstitut.
       thy, dizzin., skin reacts., sweat., arthralg., myalg., dyspn., pneum.,   ther.& in pts. exper. neurologic.effs.  inflammat. syndr., opportunist.infects. & other HIV complicat. may
       neutropen., hepatotox., hepatit., rais.liv.enzym., hypophosphataem.,   Adults: Recomm.dos.: 600 mg once dly. Adolesc. & childr.(17   still devel., monit.vir.load/CD4 count.reg., pts. to report joint pain/
       body fat accumulat./redistribut., hypertriglyceridaem., hypergly-  yrs.& und): 600 mg at bedt. Use only in adults & childr.weigh.  stiffn, advis.pt.that antiretrovir. ther. not been prov.to prev.transmiss.
       caem., proteinur., nephrogen.diab.insipid., fev., allerg.reacts., as-  great.than or equal to 40 kg.  through sex. cont./ bld.contam.& appropr.precaut.to contin., concom.
       then., weight loss, back/ chest pain, BMD decr., sev.ac.exacerbat.  Contraindications: Concom.astemizole/ cisapride /midazolam/   indinavir, monit.liv.enzym.with ritonavir, concom. methadone, ref.to
       of hepatit. B aft.discontinuat.  triazolam/pimozide/ bepridil/ ergot derivat., safety in lactat.not   prod.lit.when prescrib. other meds., consid.simultan.discont.of all
       Special precautions: Mod.to sev.ren.impairm., obesity in women   est., childr. less than 3 yrs./weigh.&lt;13 kg, concom.St John’s Wort.  antiretrovir. meds.if combinat.regim.is interrupt. because of suspect.
       & prolong.nucleoside expos.risk, liv.dis.risk fact., elderly, discont.  Side effects: Freq: Abnorm.dreams, anx., depress., insomn., diz-  intol.& restart medicat.at same time upon resolut.of intol.sympts.,
       ther.if any signs of lact.acidos./ pronounc.hepatoxic., avoid with re-  zin., imp.concentrat., headache, somnol., N&V, diarrh., dyspeps.,   intermitt. monother./sequent.reintroduct.not advis., discont. in sev.
       cent/ curr.nephrotox.agents, ren.dysfunct.risk/ hist.thereof, test for   abdom. pain, rash, erythema, diffuse maculopapul.rash, dry des-  rash & consid.prophylax.with appropr. anthistam./ corticoster.for
       hepatit.B bef.init.ther., monit. HIV/HBV co-infect.for sev.mnths.aft.  quamat., prurit., incr.sweat., fatig., pain, ALT & AST&gt;5xULN, GGT   mild to mod.rash to improv. tol.& resolv.rash, prev.ment.illn./subst.
       discont.ther., anti-hepatit.B ther.poss.init.if appropr., bone monit. in   &gt; 5xULN, amylase &gt; 2xULN, gluc.&gt; 250 mg/dL, neutrophils &lt;750/  abuse, be alert to psychos.-like reacts.& sev.ac. depress.reports, liv.
       pts.with bone fract.hist./osteopen.risk, Ca & Vit.D supplem.advis.,   mm, rais.liv.enzyme val. Aggress., agitat., emot.labil., mania, para-  dis., monit.cholestrol./ triglycerid./ liv.enzym.esp.in known/ suspect.
       discont.concom. didanosine in case of assoc.adverse effs., ataza-  noia, psychos., euphor., stupor, confus., apathy, hallucinat., suicide   hepatit. B/C infect.hist./concom. liv.tox.assoc. meds
       navir without ritonavir not recomm.concom., immune reconstit.  ideat. & attempt, nervousn., amnes., atax., cerebell. coordinat.,     Drug interactions: Plasma conc.of other compds. that are CYP3A4
       syndr., inflamm.respons.to indolent /resid.opportunist.infects.ne-  bal.disturb., convuls., abnorm.vis., tinnit., vertigo, flush., palpitat.,   substrat.poss.decr., AUC & C max of indinavir/ saquinavir/clarithro-
       cessit.furth. eval.& treatm.  tachycard., asthma, hypoesthes., paraesthes., trem., anorex., taste   mycin decr., incr. adverse effs.with ritonavir, rifampicin decr.AUC &
       Drug interactions: Ser.conc.of drugs elimin.by act.tubul.secret./  pervers., hepatit., vesiculat., moist desquamat., ulcerat., erythema   C max, methadone plasma lev.decr.& opiate withdr. signs, poss.reduc.
       Zefin may incr., poss.incr.ser. conc. by agents decr.ren.funct., AUC   multiforme, Stev.-Johns.syndr., tox. epiderm.necrolys., necros.req.  plasma conc.with St John’s Wort.
       & C max of didanosine incr., AUC & C min of atazanavir decr., incr.conc.  surg., exfoliat. dermatit., eczema, alopec., urticar., arthralg., my-
       with concom.atazanavir/lopinavir/ ritonavir.  alg., gynaecomast., allerg.react., asthen., malaise, syncope, incr.  ZOVILAM, Mylan [P/S]
                                                                  Lamivudine 150 mg, zidovudine 300 mg
                                     ser.cholester. & triglyceride conc. Unknown freq: Weight gain/
       ZELITREX, Litha [P/S]         loss, delus., neuros., completed suicide, neuropathy, URTI, sinusit.,   Indications: Treatm.of HIV- infect.as part of antiretrovir.combinat.
       Valaciclovir.                 dyspn., gastrit., gastroenterit., gastro-oesophag. reflux, incr.appet.,   ther. in adults & childr.&gt; 12 yrs with progress. immunodefic., post
       Indications: Herpes zoster (shingles), recurr. genit.herpes.in im-  constip., malabsorpt., incr.hepat.enzymes, hepat.fail., acne, seborrh./   expos. prophylax. in adults follow.occupat.expos.
       munocompetent pts., prevent/ suppress.of recurr.H.simplex infect.  photoallerg. dermatit., myopathy, impot., decr./incr.libido, influenza-  (S4) TABS, 45/20.2.8/0170
       of skin & mucous membr.of ano-genit.area, CMV infect. prophylax.,   like sympts., body fat redistribut./accumulat.  720618-001, 60, R417,12
       CMV dis.& other herpes infects.follow. organ transplant.  Special precautions: Must not be used as monother. /add.on   Dosage: .As a fix.dos.combinat.do not prescrib. when dos.adjustm.
       (S4) TABS. 32/20.2.8/0465, 29/20.2.8/0442.  as sole agent to fail.regim., vir. cross-resist.potent.if new concom.  necess., Consult respect.PI’s for separ.agents dur. combin. ther.
       852228-007: 250 mg, 60, R976,43  anti-retrovir. agents used, monit. liv.enzym.with ritonavir, concom.   Adults & childr.over 12yrs: 1 tab. 2xdly.
       817783-016: 500 mg, 10, R327,03  saquinavir as sole protease inhibit.not recomm., consid.alternat.to   Post expos.prophylax: Init.ther. pref.with.1-2 hrs aft. expos. Cont.
       817783-024: 500 mg, 30, R961,12  clarithromycin, incr. dos. with concom.rifampicin, use barrier contra-  unt.HIV status of sourceconfirm. Prophylact.course to be contin.for
       817783-008: 500 mg, 42, R1373,55  cept. in combinat.with other methods, methadone withdr., per.monit.  4 wks should source be confirm.as HIV pos. Dos: 1 tab 2x dly.for 28
       Dosage: Herpes zoster: Adults: 1 000 mg 3x/day x7 days. Chil-  anticonvuls.plasma lev., teratogen., women of child-bear.potent.to   days. Dos.to be strict.adher.to. Discont. ther.as soon as source is
       dr: No data avail.            undergo pregn.test.bef.init.ther., poss.pass.into breast milk, avoid   confirm.not to be HIV infect.
       Recurr.genit.herpes: Immunocompetent: 500 mg once dly.  high fat meals as it may incr. absorpt., discont.in sev.liv.impairm., not   Contra-indications: Abnorm.low neutrophil counts /haemoglobin
       x5 days. Immunocompromis: 500 mg 2x/day x5 days begin.  a cure, developm. of opportunist.infects.& other HIV complicat. poss.  lev., safety in pregn.not est., lactat., safety & effic.in childr.und.12 yrs.
       as early as poss.             contin., ther.not prov.to reduc. transmiss.risk, ref.to prod.lit.when pre-  not est., concom.ribavirin/stavudine/zalcitabine/emcitrabine, IV
       Prevent./suppress.of recurr.H.Simplex infect: Immunocompe-  scrib.other meds., consid.simultan.discont.of all antiretrovir. meds.   ganciclovir/foscarnet not recomm., other lamivudine contain.meds.
       tent pts: 500 mg dly. More than 10 episodes/yr: 250 mg 2xdly. Im-  if combinat.regim.is interrupt.due to suspect. intol.& restart med.at   Side-effects: Bld.dyscras., pancreatit., lact. acidos. & sev. hepato-
       munocomprom. pts: 500 mg 2xdly.  same time upon resolut. of intol.sympts., intermitt.monother./ se-  megaly with steatos., anaphylax., anorex., body fat redistribut./ ac-
       CMV infect.prophylax.& dis: Adults & adolesc. 12 yrs&   quent. reintroduct.not advis., discont.in sev. rash, consid.prophylax.  cumulat., hyperglycaem., headache, neuropathy, paraesth., periph.
       over: Init.ther.as early as poss. post-transpl. 2 000 mg 4xdly for   with appropr.anthistam.in childr., antihistam./corticoster.for mild to   neuropathy, seiz., malaise, fatig., fev., anx., depress., somnol., loss
       usual.90 days. Modify dos.in signif.ren.impairm.  mod.rash to improv.tol.& resolv.rash, nerv.syst.& psych. sympts. re-  of ment.acuit., cardiomyopathy, cough, abnorm.breath./wheez.,
       Contraindications: Acyclovir hypersens., safety in pregn.& lac-  port., be alert to psychos.-like reacts.& sev. ac.depress.incl.suicid.  dyspn., flu-like syndr., chest pain., GI disturbs., hepatotox., hepat.
       tat.not est.                  ideat./attempts.report., ment. illn./subst.abuse hist., chron.liv.dis.,   stenos., hepatit. B, splenomegaly, incr.liv.enz./bilirub.bld lev, rash,
       Side effects: Thrombot., thrombocytopen. purpura/ haemolyt.  monit. liv. enzymes partic.in known/suspect.hepatit.B/C infect. hist./  erythema multiforme, Stev-Johns.syndr., urticar., prurit., vasculit.,
       urem.syndr.in pts.with advanc. HIV dis./bone marr.-/ren.transpl.,   concom.hepatotox meds., eval.risk vs. benef. of cont.ther.if ser.  alopec., nail/skin pigmentat., sweat., myopathy, myosit., rhabdo-
       headache, naus., skin rash., GI discomf., revers.neurolog.reacts.with   transaminase.lev.persist. 5x &gt;ULN,,cholesterol./triglycerid.monit.,   myolit., arthralg., asthen., urin.freq., gynaecomast., trans. rise in
       ren.impairm./other predispos.fact., CNS effs.in CMV prophylax.pts.  heredit. disords. of galactosaem./gluc./ galact.malabsorpt. syndr.  ser.liv enz., rise in ser.amylase.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page321.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page317.html">317</a>&nbsp;&nbsp;&nbsp;<a href="page318.html">318</a>&nbsp;&nbsp;&nbsp;<a href="page319.html">319</a>&nbsp;&nbsp;&nbsp;<a href="page320.html">320</a>&nbsp;&nbsp;&nbsp;<a href="page321.html">321</a>&nbsp;&nbsp;&nbsp;<a href="page322.html">322</a>&nbsp;&nbsp;&nbsp;<a href="page323.html">323</a>&nbsp;&nbsp;&nbsp;<a href="page324.html">324</a>&nbsp;&nbsp;&nbsp;<a href="page325.html">325</a>&nbsp;&nbsp;&nbsp;<a href="page326.html">326</a>&nbsp;&nbsp;&nbsp;<a href="page327.html">327</a>
             </td>
             <td width="35%"><a href="page323.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page323.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
